These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36122284)

  • 1. Neuroleptic malignant syndrome associated with acute organophosphate poisoning: Case report.
    Angulo NY; Castaño PA; Gómez CC; Quintero S
    Biomedica; 2022 Sep; 42(3):445-449. PubMed ID: 36122284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis and treatment of neuroleptic malignant syndrome.
    Ebadi M; Pfeiffer RF; Murrin LC
    Gen Pharmacol; 1990; 21(4):367-86. PubMed ID: 1974219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome associated with atypical antipsychotics: A case report.
    Mogollon Díaz JP; Lizcano Toloza LY; Serrano García AY; Alquichire Luna CA; García Bohorquez DF; Chaparro Durán MF; Cáceres Valero MV
    Rev Colomb Psiquiatr (Engl Ed); 2023; 52(1):78-81. PubMed ID: 37031016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management challenges of a case with Flupentixol-induced neuroleptic malignant syndrome.
    Elyasi F; Sadati S; Heydari F
    Neuropsychopharmacol Rep; 2023 Mar; 43(1):154-159. PubMed ID: 36585735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome: case report and discussion.
    Chandran GJ; Mikler JR; Keegan DL
    CMAJ; 2003 Sep; 169(5):439-42. PubMed ID: 12952806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome in a postoperative patient: A case report.
    Fervienza A; López-Baamonde M; Jacas A; Muñoz G; Ibáñez C; Del Rio ME
    Rev Esp Anestesiol Reanim (Engl Ed); 2022; 69(6):364-367. PubMed ID: 35753931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome.
    Keltner NL; McIntyre CW
    J Neurosurg Nurs; 1985 Dec; 17(6):362-6. PubMed ID: 2868079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroleptic malignant syndrome - unexpected complication in a COVID-19 patient].
    Sagan J; Hýža M; Skřont T; Širůček P
    Klin Mikrobiol Infekc Lek; 2022 Sep; 28(3):69-72. PubMed ID: 36791301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy.
    Hashim H; Zeb-un-Nisa ; Alrukn SA; Al Madani AA
    J Pak Med Assoc; 2014 Apr; 64(4):471-3. PubMed ID: 24864649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report.
    Maia A; Cotovio G; Barahona-Corrêa B; Oliveira-Maia AJ
    Acta Med Port; 2021 Jun; 34(6):464-467. PubMed ID: 32997617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic Malignant Syndrome with Normal Creatine Phosphokinase Levels: An Atypical Presentation.
    Zaidi S; Irfan N; Khalid Z
    J Coll Physicians Surg Pak; 2022 Apr; 32(4):S47-S48. PubMed ID: 35633010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroleptic malignant syndrome caused by olanzapine, risperidone and haloperidol].
    Marloth PV; Ladefoged MR; Boesen MS
    Ugeskr Laeger; 2022 Nov; 184(45):. PubMed ID: 36345898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome and acute myocardial infarction: case report and review.
    Freedman MD
    Md Med J; 1997 Aug; 46(7):357-9. PubMed ID: 9260471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome: a dangerous complication of neuroleptic therapy.
    Byrd C
    J Neurosci Nurs; 1993 Feb; 25(1):62-5. PubMed ID: 8445278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant-like syndrome: a complication of acute organophosphate poisoning.
    Ochi G; Watanabe K; Tokuoka H; Hatakenaka S; Arai T
    Can J Anaesth; 1995 Nov; 42(11):1027-30. PubMed ID: 8590492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
    Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Office-based General Anesthesia for a Patient With a History of Neuroleptic Malignant Syndrome.
    Messieha ZS
    Anesth Prog; 2023 Mar; 70(1):20-24. PubMed ID: 36995955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome in a patient treated with olanzapine].
    Horni G; Meirik K; Lund MB
    Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2867-9. PubMed ID: 14600711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome: occurrence in a child after reconstructive surgery.
    Brown FE; Nierenberg DW; Nordgren RE; Taylor RM; Rozycki AA
    Plast Reconstr Surg; 1991 May; 87(5):961-4. PubMed ID: 2017509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.